Shareholders Services

Corporate Profile

WinSanTor Inc. is a private, clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo and HIV-induced peripheral neuropathy, and others. WinSanTor is currently studying its lead drug, WST-057, in a Phase 2 clinical trial in Canada for the treatment of human patients with diabetic peripheral neuropathy. Our research has been supported by leading stakeholders in the field, including the Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases (at the National Institutes of Health) and the Canadian Institutes of Health Research. We are headquartered in San Diego, California.

Investor FAQs

WinSanTor is headquartered at 7220 Trade St., Ste 370 San Diego, CA 92121

Since we are a private company, the only way to purchase stock is to be an accredited investor and to make the investment directly from the company.  If you are an accredited investor and are interested, please contact our investors department by contacting (858) 208-0546 or info@winsantor.com.

For more information to see if you are an accredited investor please check: https://www.sec.gov/files/ib_accreditedinvestors.pdf

Wilson Sonsini is our legal counsel.

An archive of WinSanTor’s press releases can be viewed at: News & Events

You can submit queries to WinSanTor’s investors department by contacting (858) 208-0546 or info@winsantor.com

Investment Portal

E-shares, once purchased, are listed and managed by the company and the investor through Capshare. Use the link below to log in or sign-up. If you have any questions, feel free to use the chat icon located on the bottom, right-hand corner of the screen.

Access Investment Portal